RxDoctor Payments Data

Douglas Matey, DO

Orthopaedic Surgery · Victoria, TXNPI 1801095831

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,869 of the $2,891 with a category attached, or 64.6%. Smith+Nephew accounts for 68.4% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2022 at $1,171 and has fallen 88.7% since, to $133 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in TX, where the typical reported total is $4,671.

$2,891in general payments, 2019–2025

Across 64 payments — averaging $45.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$2K
  • Stryker$235
  • Johnson & Johnson$110
  • Medtronic$83
  • Amgen$79
  • KCI USA, Inc.$64
  • plus $344 from 12 others

What the payments were for

  • Travel & lodging$1,02235%
  • Food & beverage$1,86965%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,891 in reported general payments places this provider in the 40th percentile of 1,337 orthopaedic surgery providers in Texas.

See all orthopaedic surgery providers in Texas →

Medicare billing

Part B allowed, 2024
$329,578
Medicare patients
567
Services billed
6,641

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban17$6,315
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen386$4,961
Acetaminophen-CodeineAcetaminophen With Codeine63$573
Meloxicam175$456
Celecoxib30$306
Methylprednisolone47$302
Tramadol Hcl57$232
Ciprofloxacin Hcl42$222
Cyclobenzaprine Hcl23$175
Mupirocin17$118
Naproxen11$111
Ondansetron OdtOndansetron12$84

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Victoria

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →